The changing market for health technologies now contains a wide variety of customers – regulators, payers, providers and patients. From a provider and payer perspective, pharmaceutical companies are frequently requested to provide economic outcomes data demonstrating the value of new and existing interventions in order to receive funding of their products. Anovák Services can assist in internal strategic decision-making and is experienced in the development of product reimbursement dossiers to provide you a direct way to optimal product reimbursement.

Next to the mandatory character of the economic outcomes evaluations, outcomes research can demonstrate the benefits of an intervention from the perspective of each of the relevant customer groups, e.g., regulators, payers, providers and patients. Anovák Services has broad experience in collecting and communicating the evidence to different customer groups.

Please contact us to discuss our comprehensive portfolio of strategic, health outcomes research and communication services.